Constantiam Biosciences
We are building a B2B computational platform to address the bottleneck of clinical genetic variant interpretation for actionable medical management.
- Stage Prototype Ready
- Industry Biotechnology
- Location Boston, MA, USA
- Currency USD
- Founded September 2020
- Employees 3
- Incorporation Type C-corp
- Website constantiambio.com
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.